The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Advocacy Highlights & Fall Treats: Reflections from the GAC Chair

Advocacy Highlights & Fall Treats: Reflections from the GAC Chair

October 21, 2022 • By Elizabeth "Blair" Solow, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

I have a special fondness for donuts, although that wasn’t always the case. As a child, I found them too sweet. My mother was kind enough to take me to the donut shop early so we could buy some before they were glazed. Over time, I grew to like cake donuts, cinnamon sugar donuts and, now, love the traditional version, although I still scrape off a lot of the sugar. It must be hereditary because my eldest does not really like donuts either—yet. I really appreciate when our nursing team brings donuts in on Friday mornings.

You Might Also Like
  • New GAC Chair Picks up the Baton
  • ACR Convergence 2021: Advocacy Successes & Challenges
  • Advocacy Leadership Conference: Reflections from an Accidental Rheumatology Advocate
Explore This Issue
November 2022

Dr. Solow

It is the small things that matter. Big numbers like $3.7 billion in lobbying money1 or 10,000 bills introduced in the 117th Congress2,3 seem overwhelming and can get in the way of the things that matter more—the impacts on our practices and patients—which brings me back to donuts. Although the donuts do help my morale, they are probably not the healthiest way to prevent burnout.4

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Advocacy may be one avenue that can help. What does it mean to lobby Congress? How will that help someone feel more empowered or experience less moral distress? During my tenure as chair of the ACR’s Government Affairs Committee (GAC), I’ve learned about the topsy-turvy rhythm of government, the role of lobbying firms, how laws are made and then interpreted on the administration side. Most importantly, I’ve learned that even a small voice—with persistence—can effect change over time. To some degree I’m preaching to the choir because you’re already reading this article, and maybe you like donuts, too. My hope is you will take this to heart and talk to your friends and colleagues about how advocacy can make a difference in the way we practice medicine and the way that we’re able to take care of our patients. We need much larger numbers lending their voices in small ways to help effect change.

Advocacy Highlights from 2022

We recently returned from lobbying Congress in September during our annual Advocates for Arthritis Hill Day, focusing on two main issues: step therapy and copay accumulator programs. In collaboration with the Committee on Research, we also met with the leadership team at the National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS) on strategic research goals and funding opportunities for rheumatology researchers.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

In my final update to you as GAC Chair, I highlight several areas of active efforts with results to date.

Pages: 1 2 3 | Single Page

Filed Under: Legislation & Advocacy Tagged With: ACR advocacy, drug pricing, Government Affairs Committee (GAC), Legislation & Advocacy, prior authorization, ReimbursementIssue: November 2022

You Might Also Like:
  • New GAC Chair Picks up the Baton
  • ACR Convergence 2021: Advocacy Successes & Challenges
  • Advocacy Leadership Conference: Reflections from an Accidental Rheumatology Advocate
  • New D.C. Office Strengthens ACR Advocacy Efforts

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)